Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

Recruiting

Early Phase 1

MetforminMetformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

Sponsor:

Anna Stanhewicz, PhD

Code:

NCT05917587

Conditions

Gestational Diabetes

Eligibility Criteria

Sex: Female

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

Metformin Hydrochloride

placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by Anna Stanhewicz, PhD on 2025-05-13.